Skip to content

The research to lung collapse under the unidirectional valve in thoracoscopic surgery: A randomized controlled trial

The research to lung collapse under the unidirectional valve in thoracoscopic surgery: A randomized controlled trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063067
Enrollment
Unknown
Registered
2022-08-30
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients scheduled to receive VATS under OLV

Interventions

Experimental group:unidirectional valve OLV
Control group:Conventional OLV

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The ASA classification is I-III; 2. Aged from 18 to 80 years old; 3. There is no obvious abnormality in lung function, FEV1/FVC > 70%, no restrictive or obstructive ventilatory dysfunction.

Exclusion criteria

Exclusion criteria: 1. The subject cannot sign the informed consent form; 2. Obesity (BMI > 30 kg/m2); 3. Heart disease: heart failure (NYHA classification > III), history of severe arrhythmia, severe bradycardia (heart rate < 45 beats/min) or atrioventricular block; 4. Severe liver and kidney diseases; 5. Patients with restrictive lung disease; 6. Those who have not completed the preoperative examination.

Design outcomes

Primary

MeasureTime frame
the time to achieve satisfactory lung collapse;

Secondary

MeasureTime frame
the probability of hypoxemia;the probability of postoperative complications;

Countries

China

Contacts

Public ContactLiang Peng

West China Hospital, Sichuan University

liangpengwch@scu.edu.cn+86 18980602201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026